Adzenys XR-ODT™ is the newest ADHD medication to be approved by the FDA. Chemically similar to Adderall, the drug is now available by prescription for children over the age of six throughout the United States. But Adzenys differs from previous generations of ADHD drugs in one major way—it is the first orange-flavored, orally dissolvable iteration of an amphetamine-based stimulant.
The release of Adzenys has caused concern among doctors and parents due to the fact that the medication is a Schedule 2 Controlled Substance, and the drug’s main selling point—its ease of use—may facilitate abuse.
Sign up for our free e-mail list to see future vaticancatholic.com videos and articles.